# Octagon Biotech Opportunities Fund II LP — Form D

Octagon Biotech Opportunities Fund II LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-07-02. The offering totals $175.0M, of which $17.8M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2026-07-02
- Form: D
- Accession: 0002132995-26-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Total offering: $175.0M
- Amount sold: $17.8M
- Remaining: $157.2M
- Minimum investment: $5.0M
- Investors: 5
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-589489

## Issuer

- Name: Octagon Biotech Opportunities Fund II LP
- CIK: 0002132995
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Address: 654 MADISON AVENUE, FL. 21, NEW YORK, NY, 10065
- Phone: 212-369-2829

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Dr. Ting Jia | Related Person | New York, NY |

## More

- [CIK 2132995 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2132995&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002132995-26-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.